The levels of alanine aminotransferase and aspartate aminotransferase may be affected by obesity (41, 42), and fluctuations in these two indicators may influence the diagnosis of PCa in a similar way that BMI influences PCa. This evidence concerns the gene GPT and obesity due to melanocortin 4 receptor deficiency.